Delivery Order SPE2DB22D3102-SPE2DB25FL1PM
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a $1,998.51 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on May 12, 2025, with completion targeted for May 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.76 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for pain management across military and federal healthcare systems....
- The Defense Logistics Agency awarded a $2,424.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials. This delivery order was issued without a set-aside designation, indicating open competition, and carries an ultimate completion date of July 7, 2025. The award was issued on July 3, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,130.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ketorolac 30 mg/ml vials. This non-set-aside contract is scheduled for completion by June 2, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Department's Medical Supply Chain has awarded a $6,176.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract was competitively awarded without set-aside provisions on August 18, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- This delivery order, awarded August 5, 2025, by the Defense Logistics Agency's Medical Supply Chain, calls for the delivery of Ketorolac 30 mg/ml vials valued at $6,477.41. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected as the prime contractor on a competitive, non-set-aside basis under firm fixed pricing. The contract specifies performance at the contractor's Conshohocken facility with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $1,298.52. This award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. As a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,886.39 to AmerisourceBergen Drug Corp for the supply of Ketorolac 60 mg/2 mL vials on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...